Outset Medical Inc (NASDAQ: OM) is -27.23% lower on its value in year-to-date trading and has touched a low of $0.44 and a high of $5.22 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The OM stock was last observed hovering at around $0.92 in the last trading session, with the day’s loss setting it -0.11%.
Currently trading at $0.81, the stock is -27.60% and -16.76% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.88 million and changing -12.17% at the moment leaves the stock -59.41% off its SMA200. OM registered -84.15% loss for a year compared to 6-month loss of -80.77%. The firm has a 50-day simple moving average (SMA 50) of $0.9653 and a 200-day simple moving average (SMA200) of $1.99702.
The stock witnessed a -37.38% gain in the last 1 month and extending the period to 3 months gives it a 32.53%, and is -42.30% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 26.56% over the week and 15.64% over the month.
Outset Medical Inc (OM) has around 480 employees, a market worth around $42.77M and $114.73M in sales. Profit margin for the company is -122.84%. Distance from 52-week low is 85.70% and -84.52% from its 52-week high. The company has generated returns on investments over the last 12 months (-56.79%).
with sales reaching $28.03M over the same period.The EPS is expected to grow by 26.00% this year, but quarterly earnings will post -13.66% year-over-year. Quarterly sales are estimated to shrink -8.09% in year-over-year returns.
Outset Medical Inc (OM) Top Institutional Holders
107.0 institutions hold shares in Outset Medical Inc (OM), with institutional investors hold 52.83% of the company’s shares. The shares outstanding are 52.54M, and float is at 48.67M with Short Float at 5.06%. Institutions hold 51.72% of the Float.
The top institutional shareholder in the company is FMR LLC with over 7.7 million shares valued at $29.63 million. The investor’s holdings represent 15.1214% of the OM Shares outstanding. As of 2024-06-30, the second largest holder is AMERIPRISE FINANCIAL INC with 5.2 million shares valued at $20.02 million to account for 10.2162 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 3.82 million shares representing 7.4955% and valued at over $14.69 million, while JPMORGAN CHASE & CO holds 5.9246 of the shares totaling 3.07 million with a market value of $11.83 million.
Outset Medical Inc (OM) Insider Activity
The most recent transaction is an insider sale by Trigg Leslie, the company’s Chair and CEO. SEC filings show that Trigg Leslie sold 33,227 shares of the company’s common stock on Jan 13 ’25 at a price of $0.81 per share for a total of $26914.0. Following the sale, the insider now owns 0.86 million shares.
Outset Medical Inc disclosed in a document filed with the SEC on Jan 13 ’25 that Nash Marc (SVP Operations and R&D) sold a total of 15,011 shares of the company’s common stock. The trade occurred on Jan 13 ’25 and was made at $0.81 per share for $12159.0. Following the transaction, the insider now directly holds 0.22 million shares of the OM stock.
Still, SEC filings show that on Jan 13 ’25, Brottem John L. (General Counsel) disposed off 20,492 shares at an average price of $0.81 for $16599.0. The insider now directly holds 205,028 shares of Outset Medical Inc (OM).
